6-Chloro-3-iodoimidazo[1,2-a]pyridine, 95.0%, 25g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-phenylalanine>98.0%(HPLC)5g

5-Azacytosine, 95.0%, 25g

2-(2,5-Dioxo-hexahydro-imidazo[4,5-d]imidazol-1-yl)-4-methylsulfanyl-butyric acid, 95+%, 1g

1-Benzyl-5-bromo-1H-indole, 97.0%, 1g

Chloroiodomethane (stabilized with Copper chip)>97.0%(GC)100g

Flacons à fond rond à trois cols cols latéraux parallèles, 4000 ml, 29/32, 14/23, 1 pièce

(E)-3-(1H-IMIDAZOL-5-YL)ACRYLIC ACID, 95%, 25g

3-(DIFLUOROMETHYL)BICYCLO[1.1.1]PENTANE-1-CARBOXYLIC ACID, 95%, 5g

4-(2,5-Dichloro-thiophen-3-yl)-thiazol-2-ylamine, 95.0%, 500mg

2-(3-Cyclopropyl-pyrazol-1-yl)-ethylamine, 95.0%, 1g

(2E)-1-(2-methoxyphenyl)-3-phenylprop-2-en-1-one, 95.0%, 10g

N-(5-chloropyridin-2-yl)acetamide, 98%, 1g